We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Liberty Broadband Class A
LBRDA
$4.14B
| $4.33M | 0.04% |
+74,365
| New | +$3.75M |
|
377
Charles River Laboratories
CRL
$10.9B
| $4.29M | 0.04% |
56,564
+41,926
| +286% | +$3.1M |
|
|
P
378
DELISTED
Pandora Media Inc
P
| $4.29M | 0.04% |
479,568
-2,224,204
| -82% | -$21.8M |
|
|
ALDR
379
DELISTED
Alder Biopharmaceuticals
ALDR
| $4.29M | 0.04% |
+175,020
| New | +$4.05M |
|
|
CALY
380
Callaway Golf Company
CALY
$3.26B
| $4.28M | 0.04% |
+468,953
| New | +$4.11M |
|
381
JD.com
JD
$40.8B
| $4.2M | 0.04% |
158,443
-67,244
| -30% | -$1.77M |
|
|
OTIC
382
DELISTED
Otonomy, Inc.
OTIC
| $4.19M | 0.04% |
+280,927
| New | +$4.41M |
|
383
Dave & Buster's
PLAY
$343M
| $4.19M | 0.04% |
+107,971
| New | +$3.95M |
|
384
Spectrum Brands
SPB
$2.04B
| $4.18M | 0.04% |
38,264
-27,891
| -42% | -$2.75M |
|
385
General Mills
GIS
$19.2B
| $4.17M | 0.04% |
+65,904
| New | +$3.83M |
|
386
Genworth Financial
GNW
$3.8B
| $4.15M | 0.04% |
1,519,390
+1,488,352
| +4,795% | +$3.77M |
|
387
Unum
UNM
$13.8B
| $4.13M | 0.04% |
133,466
+108,636
| +438% | +$3.19M |
|
388
Sun Communities
SUI
$15B
| $4.12M | 0.04% |
+57,593
| New | +$3.88M |
|
|
PRMW
389
DELISTED
Primo Water Corporation
PRMW
| $4.11M | 0.04% |
296,072
+20,055
| +7% | +$228K |
|
390
Akebia Therapeutics
AKBA
$327M
| $4.1M | 0.04% |
454,606
+82,931
| +22% | +$672K |
|
|
INFN
391
DELISTED
Infinera Corporation Common Stock
INFN
| $4.09M | 0.04% |
254,763
+10,607
| +4% | +$163K |
|
|
ELLI
392
DELISTED
Ellie Mae Inc
ELLI
| $4.08M | 0.04% |
+44,966
| New | +$3.36M |
|
393
OGE Energy
OGE
$10.3B
| $4.05M | 0.04% |
141,506
+80,928
| +134% | +$2.13M |
|
|
CLR
394
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $4.03M | 0.04% |
132,831
-163,869
| -55% | -$3.7M |
|
|
HES
395
DELISTED
Hess
HES
| $3.99M | 0.04% |
+75,725
| New | +$3.35M |
|
|
MNTA
396
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.95M | 0.04% |
+427,551
| New | +$4.6M |
|
397
Wabash National
WNC
$543M
| $3.94M | 0.04% |
+298,706
| New | +$3.49M |
|
|
DYN
398
DELISTED
Dynegy, Inc.
DYN
| $3.94M | 0.04% |
+274,285
| New | +$3.12M |
|
399
Cooper-Standard Automotive
CPS
$504M
| $3.92M | 0.04% |
54,565
+38,955
| +250% | +$2.76M |
|
400
Boeing
BA
$165B
| $3.88M | 0.04% |
30,575
-15,424
| -34% | -$1.91M |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.